Alessio Cortellini/policlinicocampusbiomedico.it
Apr 21, 2025, 11:54
Alessio Cortellini: ELCC 2025 Insights – PACIFIC Trial Analysis
Alessio Cortellini, Assistant Professor at Campus Bio-Medico University of Rome, shared a post on X by Valentina Santo, Research fellow in Thoracic Oncology at Dana-Farber Cancer Institute, adding:
“Proud of our own Leonardo Brunetti.
Post-hoc analysis of PACIFIC detrimental effect of baseline PPIs/ATB restricted to patients receiving durva, no impact on placebo.”
Quoting Valentina Santo’s post below:
“Go check Leonardo Brunetti presenting the first results of our post-hoc analysis of the PACIFIC Trial on the differential impact of PPIs and antibiotics on clinical outcomes from IO, led by him and Alessio Cortellini.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 11:54
Apr 21, 2025, 11:43
Apr 21, 2025, 11:35
Apr 21, 2025, 10:36
Apr 21, 2025, 10:34
Apr 21, 2025, 10:30
Apr 21, 2025, 10:27
Apr 21, 2025, 10:25
Apr 21, 2025, 10:22